Sarah B Doernberg
Overview
Explore the profile of Sarah B Doernberg including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
69
Citations
984
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
2.
Banerjee R, Giri A, Komarow L, Souli M, Doernberg S, Patel R
Microbiol Spectr
. 2024 Dec;
13(2):e0178924.
PMID: 39679788
In this secondary analysis of 386 subjects with Gram-negative bacteremia enrolled in the RAPIDS GN trial, rapid antibiotic susceptibility testing had a greater benefit on the management of bacteremia caused...
3.
Kinamon T, Waack U, Needles M, Rubin D, Collyar D, Doernberg S, et al.
Clin Infect Dis
. 2024 Mar;
79(1):60-69.
PMID: 38527855
Background: Desirability of outcome ranking (DOOR) is an innovative approach to clinical trial design and analysis that uses an ordinal ranking system to incorporate the overall risks and benefits of...
4.
Minter D, Appa A, Chambers H, Doernberg S
Clin Infect Dis
. 2024 Mar;
79(6):1539-1540.
PMID: 38466317
No abstract available.
5.
Paules C, Wang J, Tomashek K, Bonnett T, Singh K, Marconi V, et al.
Ann Intern Med
. 2024 Feb;
177(3):343-352.
PMID: 38408357
Background: The ACTT risk profile, which was developed from ACTT-1 (Adaptive COVID-19 Treatment Trial-1), demonstrated that hospitalized patients with COVID-19 in the high-risk quartile (characterized by low absolute lymphocyte count...
6.
Patel A, Doernberg S, Zack T, Butte A, Radtke K
Clin Pharmacol Ther
. 2024 Feb;
115(4):847-859.
PMID: 38345264
Electronic health records (EHRs) provide meaningful knowledge of drug-related adverse events (AEs) that are not captured in standard drug development and postmarketing surveillance. Using variables obtained from EHR data in...
7.
Bystritsky R, Gruenberg K, Abdoler E, Hilts-Horeczko A, Doernberg S
Antimicrob Steward Healthc Epidemiol
. 2023 Dec;
3(1):e227.
PMID: 38156222
No abstract available.
8.
Minter D, Appa A, Chambers H, Doernberg S
Clin Infect Dis
. 2023 Nov;
77(11):1489-1491.
PMID: 38031168
No abstract available.
9.
Minter D, Appa A, Chambers H, Doernberg S
Clin Infect Dis
. 2023 Nov;
77(11):e57-e68.
PMID: 37950887
Staphylococcus aureus bacteremia (SAB) carries a high risk for excess morbidity and mortality. Despite its prevalence, significant practice variation continues to permeate clinical management of this syndrome. Since the publication...
10.
Hanson K, Banerjee R, Doernberg S, Evans S, Komarow L, Satlin M, et al.
Clin Infect Dis
. 2023 Oct;
77(Suppl 4):S314-S320.
PMID: 37843119
The advancement of infectious disease diagnostics, along with studies devoted to infections caused by gram-negative and gram-positive bacteria, is a top scientific priority of the Antibacterial Resistance Leadership Group (ARLG)....